VR Logo

Sonnet BioTherapeutics Holdings Inc. (SONN) download report


Healthcare | Biotechnology & Pharma Research

Sonnet BioTherapeutics Holdings Inc. (SONN) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action.

IPO Date: 31-Oct-2006

Founder, Chairman. CEO & Pres: Dr. Pankaj Mohan Ph.D.

Chief Scientific Officer & Co-Founder: Dr. John K. Cini Ph.D.

Listing: NASDAQ: SONN

Country: United States

Headquarters: Princeton, NJ

Website: https://www.sonnetbio.com

Key Facts

Market cap: $16.30 Mln

Revenue (TTM): $0.71 Mln

Earnings (TTM): $-27.48 Mln

Cash: $13.64 Mln

Total Debt: $0.08 Mln

Insider's Holding: 3.17%

Liquidity: Low

52 Week range: $0.23 - 2.07

Shares outstanding: 60,587,900

10 Years Aggregate:

  • CFO: $-52.48 Mln
  • EBITDA: $-67.45 Mln
  • Net Profit: $-101.61 Mln

Stock Performance

Time Period Sonnet BioTherapeutics Holdings (SONN) S&P BSE Sensex* S&P Small-Cap 600*
YTD-31.71-9.18-19.27
1 month3.70-4.78-8.56
3 months-26.32-9.66-14.18
1 Year-82.050.81-17.70
3 Years-78.6110.335.88
5 Years-67.7111.345.74
10 Years-56.4511.749.77
As on 30-Jun-2022 *As on 01-Jul-2022
Year Sonnet BioTherapeutics Holdings (SONN) S&P Small-Cap 600 S&P BSE Sensex
2021-81.6125.2721.99
2020-85.469.5715.75
2019-54.2620.8614.38
2018-50.76-9.705.87
2017-37.3811.7327.91
2016-57.9724.741.95
2015-42.05-3.36-5.03